BrightFocus Award for Scientific Impact 2016

Amyloid-Beta

Principal Investigator

Stanley Prusiner, MD, PhD

University of California, San Francisco

San Francisco, CA, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$50,000

Active Dates

September 01, 2016 - August 31, 2018

Grant ID

CA2017215

Summary

The BrightFocus Foundation is pleased to offer the inaugural 2016 BrightFocus Award for Scientific Impact, presented to Dr. Prusiner on June 9, 2016, at the Mind|Sight|Cure: An Evening of BrightFocus. This award is provided to a researcher who has made groundbreaking progress toward ending diseases of mind and sight. The amount of $50,000 is to be used for Alzheimer’s disease research in Dr. Prusiner’s laboratory.

Grants

Related Grants

Alzheimer's Disease Research

Increase of ADAM10 Protein Expression in the Brain as an Alzheimer’s Disease Therapeutic

Active Dates

July 01, 2024 - June 30, 2027

Principal Investigator

Jaehong Suh, PhD

Current Organization

Massachusetts General Hospital

Alzheimer's Disease Research

Novel Molecules to Tackle Toxic Amyloid-Beta Production in Alzheimer's

Active Dates

July 01, 2023 - June 30, 2026

Principal Investigator

Lucía Chávez-Gutiérrez, PhD

Current Organization

Flanders Institute for Biotechnology (Belgium)

Alzheimer's Disease Research

Identifying Therapeutic Targets to Prevent Amyloid Accumulation

Active Dates

July 01, 2023 - June 30, 2025

Principal Investigator

Arun Upadhyay, PhD

Current Organization

Northwestern University Feinberg School of Medicine

View All